Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats
Tóm tắt
Từ khóa
Tài liệu tham khảo
Slatter, 2000, The importance of lipid-derived malondialdehyde in diabetes mellitus, Diabetologia, 43, 550, 10.1007/s001250051342
Kristal, 1997, Oxidant-mediated repression of mitochondrial transcription in diabetic rats, Free Rad Biol Med, 22, 813, 10.1016/S0891-5849(96)00429-7
Wang, 2002, Resveratrol protects against global ischemic injury in gerbils, Brain Res, 958, 439, 10.1016/S0006-8993(02)03543-6
Bonnefont-Rousselot, 2000, Consequences of the diabetic status on the oxidant/antioxidant balance, Diabet Metabol, 26, 163
Baynes, 1991, Role of oxidative stress in development of complications in diabetes, Diabetes, 40, 405, 10.2337/diabetes.40.4.405
Grene, 1999, Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy, Eur J Pharmacol, 375, 217, 10.1016/S0014-2999(99)00356-8
Low, 1997, The role of oxidative stress and antioxidant treatment in experimental diabetic neuropathy, Diabetes, 46, 38, 10.2337/diab.46.2.S38
Zaltzberg, 1999, Increased plasma oxidizability and decreased erythrocyte and plasma antioxidative capacity in patients with NIDDM, Isr Med Assoc J, 1, 228
Soleas, 1997, Wine as a biological fluid: history, production, and role in disease prevention, J Clin Lab Anal, 11, 287, 10.1002/(SICI)1098-2825(1997)11:5<287::AID-JCLA6>3.0.CO;2-4
Daniel, 1999, Selected phenolic compounds in cultivated plants: ecologic functions, health implications, and modulation by pesticides, Environ Health Perspect, 107, 109, 10.1289/ehp.99107s1109
Sobolev, 1999, Trans-resveratrol content in commercial peanuts and peanut products, J Agric Food Chem, 47, 1435, 10.1021/jf9809885
Inoue, 1999, Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells, Biochem Biophys Res Commun, 254, 292, 10.1006/bbrc.1998.9939
Sinha, 2002, Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats, Life Sci, 71, 655, 10.1016/S0024-3205(02)01691-0
Inoue, 2000, Feedback control of cyclooxygenase-2 expression through PPARgamma, J Biol Chem, 275, 28028, 10.1074/jbc.M001387200
Huang, 2001, Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia, Life Sci, 69, 1057, 10.1016/S0024-3205(01)01195-X
Bloomfield Rubins, 2001, Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT), Circulation, 103, 2828, 10.1161/01.CIR.103.23.2828
Kimura, 1985, Effects of stilbenes on arachidonate metabolism in leukocytes, Biochem Biophys Acta, 834, 275, 10.1016/0005-2760(85)90167-5
Bao, 2003, Effects of resveratrol on secondary damages after acute spinal cord injury in rats, Acta Pharmacol Sin, 24, 703
Montilla, 1998, Oxidative stress in diabetic rats induced by streptozotocin: Protective effects of melatonin, J Pineal Res, 25, 94, 10.1111/j.1600-079X.1998.tb00545.x
Sailaja Devi, 2000, Preservation of the antioxidant status in chemically-induced diabetes mellitus by melatonin, J Pineal Res, 29, 108, 10.1034/j.1600-079X.2000.290207.x
Uchiyama, 1978, Determination of malonaldehyde precursor in tissues by thiobarbituric acid test, Anal Biochem, 86, 271, 10.1016/0003-2697(78)90342-1
Prajda, 1975, Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas, FEBS Lett, 59, 245, 10.1016/0014-5793(75)80385-1
Jungersten, 1996, Plasma nitrate as an index of nitric oxide formation in man: analyses of kinetics and confounding factors, Clin Physiol, 16, 369, 10.1111/j.1475-097X.1996.tb00726.x
Zeballos, 1995, Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs, Circulation, 91, 2982, 10.1161/01.CIR.91.12.2982
Ozbek, 2000, Increased nitric oxide production in the spermatic vein of patients with varicocele, Eur Urol, 37, 172, 10.1159/000020135
Baydas, 2003, Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats, Free Radic Biol Med, 35, 797, 10.1016/S0891-5849(03)00408-8
Sano, 1998, Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes, Diabetologia, 41, 1355, 10.1007/s001250051076
Tadolini, 2000, Resveratrol inhibition of lipid peroxidation, Free Radic Res, 33, 104, 10.1080/10715760000300661
Sun, 1997, Ethanol-induced cell death by lipid peroxidation in PC 12 cells, Neurochem Res, 22, 1187, 10.1023/A:1021968526696
Zini, 1999, Effects of resveratrol on the rat brain respiratory chain, Drugs Exp Clin Res, 25, 87
Mizutani, 2001, Protective effective of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats, Clin Exp Pharmacol Physiol, 28, 55, 10.1046/j.1440-1681.2001.03415.x
Virgili, 2000, Partial neuroprotection of in vivo exictotoxic brain damage by chronic administration of the red wine antioxidant agents, trans-resveratrol in rats, Neurosci Lett, 281, 123, 10.1016/S0304-3940(00)00820-X
Bhattacharyya, 1992, S100 is present in developing chicken neurones, and Schwann cells, and promotes neuron survival in vivo, J Neurobiol, 23, 451, 10.1002/neu.480230410
Moosmann, 2002, Antioxidants as treatment for neurodegenerative disorders, Expert Opin Investig Drugs, 11, 1407, 10.1517/13543784.11.10.1407
Matkovics, 1997, Oxidative stress in experimental diabetes induced by streptozotocin, Acta Physiol Hung, 85, 29
Schein, 1973, Streptozotocin diabetes – further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in Mouse pancreatic islets and liver, Biochem Pharmacol, 22, 2625, 10.1016/0006-2952(73)90071-3
Hawkins, 2001, Generation and propagation of radical reactions on proteins, Biochem Biophys Acta, 1504, 196, 10.1016/S0005-2728(00)00252-8
Luxford, 2000, Radicals derived from histone hydroperoxides damage nucleobases in RNA and DNA, Chem Res Toxicol, 13, 665, 10.1021/tx000053u
McLennan, 1991, Changes in hepatic glutathione metabolism in diabetes, Diabetes, 40, 344, 10.2337/diabetes.40.3.344
Mullarkey, 1990, Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes, Biochem Biophys Res Commun, 173, 932, 10.1016/S0006-291X(05)80875-7
Dincer, 2002, Effect of oxidative stress on glutathione pathway in red blood cells from patients with insulin-dependent diabetes mellitus, Metabolism, 51, 1360, 10.1053/meta.2002.35192
Tachi, 2001, Hyperglycemia in diabetic rats reduces the glutathione content in the aortic tissue, Life Sci, 69, 1039, 10.1016/S0024-3205(01)01183-3
Hile, 1995, Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase, FASEB J, 9, 995, 10.1096/fasebj.9.11.7649415
Corte, 1972, The regulation of rat liver xanthine oxidase. Involvement of thiol groups in the conversion of the enzyme activity from dehydrogenase (type D) into oxidase (type O) and purification of the enzyme, Biochem J, 126, 739, 10.1042/bj1260739
Matsumoto, 2003, Confirmation of superoxide generation via xanthine oxidase in streptozotocin-induced diabetic mice, Free Radic Res, 37, 767, 10.1080/1071576031000107344
Parks, 1988, Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: A reevaluation, Am J Physiol, 254, 768
Desco, 2002, Xanthine oxidase is involved in free radical production in type 1 diabetes: Protection by allopurinol, Diabetes, 51, 1118, 10.2337/diabetes.51.4.1118
Moncada, 1993, The L-arginine-nitric oxide pathway, N Engl J Med, 329, 2002, 10.1056/NEJM199312303292706
Peunova, 1993, Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells, Nature, 364, 450, 10.1038/364450a0